Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pulmonology ; 29 Suppl 4: S18-S24, 2023 Dec.
Article in English | MEDLINE | ID: mdl-34281801

ABSTRACT

BACKGROUND AND OBJECTIVES: In patients with pulmonary hypertension (PH), shortness of breath, fatigue, chest pain, and syncope limit exercise capacity. Exercise tests are often time-consuming, expensive, and some patients may not be able to perform such procedures and they are also difficult to apply in the studies including large samples. The aim of this study was to translate and culturally adapt the DASI into Turkish and to investigate its reliability and validity in patients with PH. METHODS: The final Turkish version of the DASI questionnaire was applied to 109 clinically stable patients with a diagnosis of PH. Exercise capacity of the patients was determined by maximal VO 2 achieved in the 6-minute walk test (6MWT) and quality of life by the EmPHasis-10 questionnaire. Cronbach alpha (internal consistency) was used to assess the questionnaire's reliability. The validity assessment was performed by using Spearman correlation. RESULTS: Internal consistency of the DASI was high (Cronbach's alpha = 0.99) and the test-retest reliability was excellent (ICC = 0.98). Validity was supported by significant correlations of DASI-VO 2 scores with estimated VO 2 (6MWT) scores (r = 0.58, p < 0.0001) and EmPHasis-10 (= -0.62, p < 0.0001). No floor or ceiling effect was present for the questionnaire. CONCLUSIONS: The Turkish version of the culturally adapted DASI questionnaire was found to be a valid and reliable assessment tool. It is a rapidly administered, simple-toscore questionnaire for assessing the functional ability of individuals with PH. The use of the DASI to assess exercise capacity in patients with PH may assist researchers and clinicians detecting functional impairment in these patients.


Subject(s)
Cross-Cultural Comparison , Hypertension, Pulmonary , Humans , Quality of Life , Hypertension, Pulmonary/diagnosis , Reproducibility of Results , Exercise Test , Surveys and Questionnaires
2.
QJM ; 114(9): 642-647, 2021 Nov 13.
Article in English | MEDLINE | ID: mdl-33486512

ABSTRACT

BACKGROUND: COVID-19 has challenged the health system organization requiring a fast reorganization of diagnostic/therapeutic pathways for patients affected by time-dependent diseases such as acute coronary syndromes (ACS). AIM: To describe ACS hospitalizations, management, and complication rate before and after the COVID-19 pandemic was declared. DESIGN: Ecological retrospective study. Methods: We analyzed aggregated epidemiological data of all patients > 18 years old admitted for ACS in twenty-nine hub cardiac centers from 17 Countries across 4 continents, from December 1st, 2019 to April 15th, 2020. Data from December 2018 to April 2019 were used as historical period. RESULTS: A significant overall trend for reduction in the weekly number of ACS hospitalizations was observed (20.2%; 95% confidence interval CI [1.6, 35.4] P = 0.04). The incidence rate reached a 54% reduction during the second week of April (incidence rate ratio: 0.46, 95% CI [0.36, 0.58]) and was also significant when compared to the same months in 2019 (March and April, respectively IRR: 0.56, 95%CI [0.48, 0.67]; IRR: 0.43, 95%CI [0.32, 0.58] p < 0.001). A significant increase in door-to-balloon, door-to-needle, and total ischemic time (p <0.04 for all) in STEMI patents were reported during pandemic period. Finally, the proportion of patients with mechanical complications was higher (1.98% vs. 0.98%; P = 0.006) whereas GRACE risk score was not different. CONCLUSIONS: Our results confirm that COVID-19 pandemic was associated with a significant decrease in ACS hospitalizations rate, an increase in total ischemic time and a higher rate of mechanical complications on a international scale.


Subject(s)
Acute Coronary Syndrome , COVID-19 , Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/therapy , Adolescent , Hospitalization , Humans , Pandemics , Retrospective Studies , SARS-CoV-2
3.
Herz ; 39(7): 887-9, 2014 Nov.
Article in English | MEDLINE | ID: mdl-23903363

ABSTRACT

Heparin-induced thrombocytopenia (HIT) is the most important and the most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant mortality and morbidity if unrecognized. We describe a patient with a giant thrombus on the apical wall of the left ventricle that occurred due to HIT syndrome after anterior myocardial infarction.


Subject(s)
Enoxaparin/adverse effects , Myocardial Infarction/complications , Thrombocytopenia/chemically induced , Thrombocytopenia/prevention & control , Thrombosis/chemically induced , Thrombosis/prevention & control , Anticoagulants/adverse effects , Anticoagulants/therapeutic use , Enoxaparin/therapeutic use , Heart Ventricles/diagnostic imaging , Humans , Male , Middle Aged , Myocardial Infarction/drug therapy , Thrombocytopenia/diagnosis , Thrombosis/diagnosis , Treatment Outcome , Ultrasonography
4.
Herz ; 37(5): 567-9, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22407420

ABSTRACT

Pulmonary arteriovenous malformations (PAVM) consist of an abnormal connection between the pulmonary artery and vein bypassing the pulmonary capillary bed. Pulmonary arteriovenous fistulae are characterized by a right-to-left shunt of variable magnitude, and they may be accompanied by other congenital anomalies. We describe a case of pulmonary arteriovenous fistula with a secundum type atrial septal defect (ASD) in a 38-year-old woman, who underwent successful transcatheter closure of both the ASD and PAVM.


Subject(s)
Arteriovenous Fistula/complications , Arteriovenous Fistula/diagnosis , Heart Septal Defects, Atrial/complications , Heart Septal Defects, Atrial/diagnosis , Stroke/diagnosis , Stroke/etiology , Adult , Diagnosis, Differential , Female , Humans , Pulmonary Artery/abnormalities , Pulmonary Veins/abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...